WESTBROOK, Maine, Jan. 13, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One(TM) Chemistry Analyzer.
AI-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases The global launch of the IDEXX inVue Dx analyzer ...
WESTBROOK, Maine - IDEXX Laboratories, Inc. (NASDAQ: IDXX) has announced the introduction of the IDEXX inVue Dx™ Cellular Analyzer. This new device is touted as a revolutionary tool for veterinary ...
IDEXX Laboratories, Inc. IDXX launched a rapid digital cytology service namely IDEXX Digital Cytology, powered by its VetConnect PLUS software. The cytology service will digitally connect ...
IDEXX Laboratories, Inc. IDXX recently launched its first veterinary diagnostic test, IDEXX Cystatin B, for detecting kidney injury in cats and dogs. This can help veterinary professionals to spot ...
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a leader in veterinary diagnostics and software, has been navigating a complex market landscape characterized by fluctuating veterinary visit trends and ...
Advanced technology expands the leading line of IDEXX point-of-care analyzers and combines a full chemistry panel with electrolytes and total T4 (thyroxine) into a single sample run to deliver ...
AI-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases The global launch of the IDEXX inVue Dx analyzer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback